← FDA DRUG APPROVALS

FDA NDA · NDA019545

DIDRONEL

Sponsor: MGI PHARMA INC

APPLICATION
NDA019545
TYPE
NDA
ORIGINAL APPROVAL
1987-04-20
LATEST ACTION
2002-06-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DIDRONELDiscontinued
ETIDRONATE DISODIUM 50MG/ML · INJECTABLE · INJECTION

Approval history

2002-06-26Manufacturing (CMC) · Supplement 6 · standardAP
1998-09-22Labeling · Supplement 5 · standardAP
1998-04-01Labeling · Supplement 4 · standardAP
1993-09-28Labeling · Supplement 3 · standardAP
1992-07-21Manufacturing (CMC) · Supplement 2 · standardAP
1992-01-28Manufacturing (CMC) · Supplement 1 · standardAP
1987-04-20Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →